Research Analysts Set Expectations for Teradyne Q1 Earnings

Teradyne, Inc. (NASDAQ:TERFree Report) – Investment analysts at Zacks Research upped their Q1 2026 earnings per share (EPS) estimates for shares of Teradyne in a research note issued on Tuesday, August 19th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $0.87 for the quarter, up from their previous forecast of $0.86. The consensus estimate for Teradyne’s current full-year earnings is $3.88 per share. Zacks Research also issued estimates for Teradyne’s Q2 2026 earnings at $0.83 EPS, Q4 2026 earnings at $1.14 EPS, Q1 2027 earnings at $1.12 EPS, Q2 2027 earnings at $1.06 EPS and FY2027 earnings at $4.89 EPS.

Teradyne (NASDAQ:TERGet Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.03. The business had revenue of $651.80 million during the quarter, compared to analyst estimates of $649.02 million. Teradyne had a return on equity of 18.16% and a net margin of 16.59%.The company’s revenue for the quarter was down 10.7% on a year-over-year basis. During the same period last year, the company earned $0.86 EPS. Teradyne has set its Q3 2025 guidance at 0.690-0.870 EPS.

A number of other equities research analysts have also issued reports on TER. Cantor Fitzgerald set a $105.00 price target on Teradyne and gave the stock an “overweight” rating in a research note on Tuesday, June 24th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $102.00 price target (up from $88.00) on shares of Teradyne in a report on Thursday, July 17th. Wall Street Zen upgraded Teradyne from a “sell” rating to a “hold” rating in a report on Saturday, August 16th. UBS Group restated a “buy” rating and set a $130.00 target price (up from $120.00) on shares of Teradyne in a research note on Thursday, July 31st. Finally, The Goldman Sachs Group reaffirmed a “sell” rating and set a $85.00 price target on shares of Teradyne in a research report on Wednesday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $114.44.

Check Out Our Latest Analysis on Teradyne

Teradyne Price Performance

NASDAQ:TER opened at $115.30 on Friday. The firm has a market capitalization of $18.34 billion, a price-to-earnings ratio of 39.90, a PEG ratio of 2.30 and a beta of 1.72. Teradyne has a 1 year low of $65.77 and a 1 year high of $144.16. The business has a 50 day simple moving average of $97.69 and a 200-day simple moving average of $91.31.

Institutional Investors Weigh In On Teradyne

Several large investors have recently bought and sold shares of TER. Snowden Capital Advisors LLC grew its position in Teradyne by 2.8% in the 4th quarter. Snowden Capital Advisors LLC now owns 3,748 shares of the company’s stock worth $472,000 after purchasing an additional 103 shares during the last quarter. Fulton Bank N.A. grew its stake in shares of Teradyne by 4.3% in the 2nd quarter. Fulton Bank N.A. now owns 2,722 shares of the company’s stock valued at $245,000 after purchasing an additional 113 shares during the period. HighTower Advisors LLC grew its stake in shares of Teradyne by 1.0% in the 1st quarter. HighTower Advisors LLC now owns 12,528 shares of the company’s stock valued at $1,035,000 after purchasing an additional 124 shares during the period. Manchester Capital Management LLC grew its stake in shares of Teradyne by 29.4% in the 2nd quarter. Manchester Capital Management LLC now owns 586 shares of the company’s stock valued at $53,000 after purchasing an additional 133 shares during the period. Finally, MassMutual Private Wealth & Trust FSB grew its stake in shares of Teradyne by 22.2% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 820 shares of the company’s stock valued at $68,000 after purchasing an additional 149 shares during the period. 99.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Teradyne news, CEO Gregory Stephen Smith sold 554 shares of the business’s stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $106.00, for a total transaction of $58,724.00. Following the completion of the sale, the chief executive officer directly owned 96,993 shares in the company, valued at approximately $10,281,258. The trade was a 0.57% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.16% of the company’s stock.

Teradyne announced that its board has authorized a stock repurchase plan on Monday, April 28th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 8.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s management believes its stock is undervalued.

Teradyne Company Profile

(Get Free Report)

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

See Also

Earnings History and Estimates for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.